Graceway Announces Journal Of The American Academy Of Dermatology Publishes Articles On New Short-Course Imiquimod Formulation In Actinic Keratosis
Source: Medical News Today
Wednesday 10th March, 2010
0 posts The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily ... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story